Home Nav
Nextech Invest Logo

Thilo Schroeder

Alfred Scheidegger

Thilo Schroeder, Ph.D. is Partner at Nextech Invest Ltd., a global venture fund focused on investing in leading oncology companies. Prior to joining Nextech Invest in 2012, Dr. Schroeder worked in research specializing on the development of Designed Ankyrin Repeat Proteins (DARPins) as specific protein inhibitors (licensed to Molecular Partners / SWX:MOLN). He acquired expertise in molecular biology as an Intern at Micromet Ltd. (now Amgen) and during his studies at the University of Sydney. Dr. Schroeder currently serves as board member of Revolution Medicines, IDEAYA Bioscience, ImaginAb and board observer of Peloton Therapeutics. He is a prior board member of Blueprint Medicines (NASDAQ:BPMC), SiROP Global, and board observer of Tracon Pharmaceuticals (NASDAQ:TCON). He holds a Ph.D. in biochemistry from the University of Zurich in Switzerland, a M.Sc. in biotechnology from the Ecole de Supérieure de Biotechnologie de Strasbourg in France, and a B.Sc. in biology from the Technical University of Darmstadt in Germany.

Mr. Schroeder is responsible for the following Nextech portfolio companies:

Revolution Medicines, Peloton Therapeutics, Kura Oncology, ImaginAb, IDEAYA Biosciences, Black Diamond Therapeutics

Portfolio companies Mr. Schroeder has been involved with previously:

Blueprint Medicines, Jounce Therapeutics

 

Personalized Oncology 2019 conference

23.06. – 25.06.2019

Basel, Switzerland

  • 14.06.2019

    Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib...

  • 14.06.2019

    Blueprint Medicines Submits New Drug Application to...

  • 04.06.2019

    Arvinas and Bayer to Collaborate on Human PROTAC® Therapies...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close